1. Condition of the higher brain functions in patients with dyscirculatory encephalopathy treated with mildronate;Abeuov;Meditsina,2004
2. Comparative characteristics of cerebrovascular protective effects of mildronate, riboxine, and their combination during modeling of cerebral hemodynamics disturbance;Beketov;Éksp Klin Farmakol,2000
3. Absence of mutagenic and carcinogenic properties in mildronate;Belitskii;Vopr Onkol,1999
4. Influence of the Mildronate on intensity of the ADP-ribosylation of chromatin proteins;Blium;Latv Zinatnu Akad Vestis,1990
5. Effect of quaterin and S-methylmethionine on the intensity of chromatin protein methylation;Blium;Voen-Med Zh,1987